Class I
Ongoing
Heparin (Heparin Sodium in 0.9% Sodium Chloride Injection), 2,000 units per 1,000 mL (2 units/mL), 1000 mL Sterile Single Dose Container, Rx Only, Baxter USA, NDC 0338-0433-04
This recall is currently active, issued September 11, 2024. It was issued by Baxter Healthcare Corporation.
- Company
- Baxter Healthcare Corporation
- Recall Initiated
- August 1, 2024
- Posted
- September 11, 2024
- Recall Number
- D-0649-2024
- Voluntary / Mandated
- Voluntary: Firm initiated
- Quantity
- 44,208 containers
- Firm Location
- Round Lake, IL, United States
- Official Source
- View on FDA website ↗
Reason for Recall
Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
Distribution
Nationwide in the USA
Lot / Code Info
Lot # N008235, Exp 8/31/2024
More recalls by Baxter Healthcare Corporation
Kaguya Automated Peritoneal Dialysis System
Jun 30, 2021
Other recent Class I Drug recalls
UDENYCA, pegfilgrastim-cbqv injection, 6 mg/0.6mL Single Dose Prefilled Syringe, Rx only, Manufactu...
Mckesson
· Feb 18, 2026
Green Lumber Natural Fuel For Men capsule, packaged in 2, 4, 10, and 30-count blister packs. GreenLu...
Green Lumber Holdings, Llc
· Feb 11, 2026
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India...
Handelnine Global Llc
· Feb 11, 2026
ClearLife Allergy Nasal Spray, Extra Strength, 0.68 fl. oz. (20 mL) bottles, Distributed by: MediNat...
Medinatura New Mexico, Inc.
· Jan 14, 2026
Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, L...
Fresenius Kabi Usa, Llc
· Dec 3, 2025